Website & contact details
- Group website
- The site of this company’s group or brand.
Bioline Reagents Limited
- Incorporated
- 19 July 2003 (23 years)
- Previously known as
- Quantace Limited (until 8 February 2010)
- Industry
- Manufacture of other chemical products n.e.c. (20590)
- Directors
- Harald Henri OttenhofEmerson Moser
- Accounts type
- Full
- Region
- Greater London
- Address
- 16 The Edge Business CentreHumber RoadLondonNW2 6EW
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 25 April 2027
- Last conf. stmt
- 11 April 2026
Charges
- Total
- 4
- Outstanding
- 4
- Part satisfied
- 0
- Satisfied
- 0
Officers 3 active
Officer details are public data from the Companies House register.
Ottenhof, Harald Henri, Dr
Director · Appointed 1 June 2026
Dutch
Born September 1977 (49)
Moser, Emerson
Director · Appointed 1 July 2023
American
Born June 1976 (50)
Director · Appointed 23 March 2022
American
Born March 1979 (47)
Officer history (19 former)
1 June 2026
Appointed Ottenhof, Harald Henri, Dr as Director
8 August 2025
Resigned Weltzien, De Lourdes Guerra as Director
1 July 2023
Appointed Moser, Emerson as Director
30 June 2023
31 January 2023
23 March 2022
23 March 2022
23 March 2022
Resigned Parker, Alan as Secretary
23 March 2022
31 December 2021
Resigned Baldasare, Bryan as Director
28 August 2020
Resigned Ottenhof, Harald Henri as Director
28 August 2020
Appointed Weltzien, De Lourdes Guerra as Director
25 June 2019
Appointed Baldasare, Bryan as Director
21 June 2019
25 January 2019
13 December 2018
Resigned Lueke, Melissa Ann as Director
12 June 2018
Appointed Ottenhof, Harald Henri as Director
12 June 2018
20 February 2018
Resigned Eberly, Richard Lee as Director
23 January 2018
23 January 2018
26 January 2017
Appointed Lueke, Melissa Ann as Director
29 January 2016
Resigned Hirani, Kasturben as Director
14 September 2012
Appointed Parker, Alan as Secretary
14 September 2012
14 September 2012
Appointed Eberly, Richard Lee as Director
14 September 2012
1 September 2009
Appointed Hirani, Kasturben as Director
1 September 2009
5 April 2009
Resigned Legrand, Eugene Lewis as Director
1 November 2008
Resigned Taylor, Simon as Secretary
3 September 2008
3 September 2008
Appointed Legrand, Eugene Lewis as Director
31 March 2008
31 March 2008
Resigned Legrand, Eugene Lewis as Director
17 January 2007
11 November 2005
19 July 2003
19 July 2003
19 July 2003
Appointed Legrand, Eugene Lewis as Director
19 July 2003
Appointed Taylor, Simon as Secretary
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Limited Company
Reg. no. 8971622
Group structure 3 companies
Ownership group derived from the Companies House PSC register
Bioline Reagents Limited This company Owns 75–100% of shares
Meridian Bioscience UK Limited Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £7,777,773
- Cash
- £2,818,907
- Turnover
- £17,077,400
- Profit Before Tax
- £9,436,137
- Employees
- 36
- Debt Ratio
- 20%
- Current Ratio
- 5.0x
- Profit Margin
- 55%
- Return on Equity
- 90%
Trend
Turnover
Balance sheet detail
| 2024 | 2023 | |
|---|---|---|
| Fixed Assets | £259,485 | £335,523 |
| Current Assets | £9,429,158 | £9,295,108 |
| Cash | £2,818,907 | £3,577,928 |
| Creditors (< 1 year) | £1,879,954 | £2,796,822 |
| Net Current Assets | £7,549,204 | £6,498,286 |
| Net Assets | £7,777,773 | £6,787,768 |
| Shareholder Funds | £7,777,773 | £6,787,768 |
| Turnover | £17,077,400 | £21,102,581 |
| Cost of Sales | £2,660,973 | £5,221,992 |
| Gross Profit | £14,416,427 | £15,880,589 |
| Admin Expenses | £5,072,513 | £6,290,441 |
| Staff Costs | £2,891,740 | £3,406,292 |
| Operating Profit | £9,458,971 | £9,715,163 |
| Profit Before Tax | £9,436,137 | £9,689,418 |
| Tax | £2,446,132 | £2,152,018 |
| Profit for Period | £6,990,005 | £7,537,400 |
Filings 104
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 23 September 2026 | Full accounts | 31 December 2025 | ||
| 10 June 2026 | Appointment of a director | |||
| 1 May 2026 | Confirmation statement with no updates | 11 April 2026 | ||
| 30 April 2026 | Replacement filing for the appointment of a director | |||
| 15 September 2025 | Full accounts | 31 December 2024 |
Other companies in this industry
Newton Abbot
Birmingham
Wickford
Peterborough
Glasgow
Nottingham
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →